Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectiveness
Gene therapy approaches now allow for the production of therapeutic antibodies by healthy or cancerous human tissues directly in vivo, and, with an increasing number of gene delivery methods available, the cell type for expression can be chosen. Yet, little is known about the biophysical changes int...
Saved in:
Main Authors: | Dominik Brücher (Author), Vojtech Franc (Author), Sheena N. Smith (Author), Albert J. R. Heck (Author), Andreas Plückthun (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Physiological relevance of protein-glycosylation to pathogenesis of diabetes
by: Kazuaki Ohtsubo, et al.
Published: (2014) -
Malignant peripheral nerve sheath tumor with divergent differentiation
by: Suresh T, et al.
Published: (2009) -
Engineered Fc-glycosylation switch to eliminate antibody effector function
by: Qun Zhou, et al.
Published: (2020) -
Characterization of N-Linked Glycosylation in a Monoclonal Antibody Produced in NS0 Cells Using Capillary Electrophoresis with Laser-Induced Fluorescence Detection
by: Yang Wang, et al.
Published: (2013) -
Characterization of high-molecular weight by-products in the production of a trivalent bispecific 2+1 heterodimeric antibody
by: Dario A. T. Cramer, et al.
Published: (2023)